#
المجال البحثي
1
2 Characterization of Integron and New Resistant Genes in Pathogenic Bacteria
3Application of Nanotechnology in Diagnosis and treatment of Infectious diseases
4application of nanotechnology in treatment and diagnosis of infectious diseases
5Biosensors
6biotechnology
7Biotechnology: Production of new biologically active compounds using bacterial
8Cancer Biology
9cardiovascular risk factors
10Computer aided drug discovery
11Design and synthesis of Antiviral nucleoside analogues
12Design and synthesis of Mannich bases of potential pharmacological activity
13Design and synthesis of thioxoimidazolidinone derivatives
14Development of A New Method for Rapid Detection of Carbapenemases
15Development of new vaccine for HCV
16Development of validated analytical method for quality and efficacy assurance of certain drugs
17Development of Various Instrumental Analysis Techniques for Determination of Certain Antipsychotic Pharmaceutical Compounds and Their Applications in Pharmaceutical Formulations
18Drug disocvery
19drug therapy for erection
20herbal therapy for erection
21medicinal chemistry and drug design
22microbiology and immunology
23Molecular Characterization of Carbapenemases in Gram negative Clinical Bacterial Isolates
24Molecular characterization of Integron in Some Multi-Drug resistant Enterobacter species isolated from clinical samples
25Molecular Characterization of Metallo-Beta-Lactamses Produced by Gram Negative Bacteria
26Molecular Detection of Biofilm Forming Genes in some Bacterial Species
27Molecular docking and synthesis of thiohydantoin derivatives as Antiprostate cancer
28Molecular docking and synthesis of thiohydantoin derivatives for treatment of breast cancer
29Molecular docking of potential anti leukemia Drugs
30molecular microbiology
31Natural products chemistry
32pharmacokinetics
33pharmacy practice
34Quantum activity relationships of some anticancer drugs
35Role of Transposones and Insersion Sequence Element(ISE) in Developing Antimicrobial Resistance
36Spectrofluorimetric Determination of Drugs Containing α-Methylene Carbonyl Functional Groups Using N1-Methylnicotinamide Chloride as a Fluorogenic Agent and Synthesis of Fluorescent Product for Certain α-Methylene Carbonyl Compounds
37synthesis of new molecular entity
38The role of bacteria in biodegradation of xenobiotics
39Traditional medicine
40virology